U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry MIXED
Molecular Formula 2C13H29N.C6H10O8
Molecular Weight 608.8909
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OCTAMYLAMINE MUCATE

SMILES

CC(C)CCCC(C)NCCC(C)C.CC(C)CCCC(C)NCCC(C)C.O[C@@H]([C@@H](O)[C@H](O)C(O)=O)[C@@H](O)C(O)=O

InChI

InChIKey=UJGUOLMDGMDNGF-IBGZLQDMSA-N
InChI=1S/2C13H29N.C6H10O8/c2*1-11(2)7-6-8-13(5)14-10-9-12(3)4;7-1(3(9)5(11)12)2(8)4(10)6(13)14/h2*11-14H,6-10H2,1-5H3;1-4,7-10H,(H,11,12)(H,13,14)/t;;1-,2+,3+,4-

HIDE SMILES / InChI

Molecular Formula C13H29N
Molecular Weight 199.3761
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula C6H10O8
Molecular Weight 210.1388
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Octamylamine is an Antispasmodic. Trademark: Octinum D.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Octinum-D

Approved Use

Antispasmodic; for digestive, urinary tract and sphincter cramps, migraine headaches, urinary tract and hiccup, gastrointestinal tract equipment examination. For canker, cholecystitis, cholelithiasis diseases caused by abdominal pain, and the effect of atropine similar, but no other adverse reactions, dry mouth.
PubMed

PubMed

TitleDatePubMed
[Octinum D in the development of synthetic spasmolytics].
1952 Apr
[Pylorus hypertrophy in adults, x-rayed while under effect of octin D].
1953
[Octin, hydro-octin, octin D; a contribution to the analysis of their mechanism of action].
1955
Patents

Sample Use Guides

Oral: Each compound drops 25 to 40 drops
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:34:51 GMT 2023
Edited
by admin
on Sat Dec 16 09:34:51 GMT 2023
Record UNII
L9S34T2T2J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OCTAMYLAMINE MUCATE
WHO-DD  
Common Name English
GALACTARIC ACID, COMPD. WITH 6-METHYL-N-(3-METHYLBUTYL)-2-HEPTANAMINE (1:2)
Systematic Name English
6-METHYL-N-(3-METHYLBUTYL)-2-HEPTANAMINE - D-GALACTARIC ACID (2:1)
Systematic Name English
OCTAMYLAMINE GALACTARIC ACID SALT
Common Name English
J321.966F
Code English
2-HEPTANAMINE, 6-METHYL-N-(3-METHYLBUTYL)-, GALACTARATE (2:1)
Systematic Name English
6-METHYL-N-(3-METHYLBUTYL)HEPTAN-2-AMINE, (2S,3R,4S,5R)-2,3,4,5-TETRAHYDROXYHEXANEDIOIC ACID
Systematic Name English
GALACTARIC ACID, COMPOUND WITH 1,5-DIMETHYL-N-(3-METHYLBUTYL)HEXYLAMINE (1:2)
Common Name English
Octamylamine mucate [WHO-DD]
Common Name English
Code System Code Type Description
EVMPD
SUB03482MIG
Created by admin on Sat Dec 16 09:34:51 GMT 2023 , Edited by admin on Sat Dec 16 09:34:51 GMT 2023
PRIMARY
CAS
93918-97-9
Created by admin on Sat Dec 16 09:34:51 GMT 2023 , Edited by admin on Sat Dec 16 09:34:51 GMT 2023
PRIMARY
ECHA (EC/EINECS)
299-979-7
Created by admin on Sat Dec 16 09:34:51 GMT 2023 , Edited by admin on Sat Dec 16 09:34:51 GMT 2023
PRIMARY
PUBCHEM
44151233
Created by admin on Sat Dec 16 09:34:51 GMT 2023 , Edited by admin on Sat Dec 16 09:34:51 GMT 2023
PRIMARY
SMS_ID
100000085727
Created by admin on Sat Dec 16 09:34:51 GMT 2023 , Edited by admin on Sat Dec 16 09:34:51 GMT 2023
PRIMARY
FDA UNII
L9S34T2T2J
Created by admin on Sat Dec 16 09:34:51 GMT 2023 , Edited by admin on Sat Dec 16 09:34:51 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY